Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia.
Although very low density lipoprotein (VLDL) receptor expression by macrophages has been shown in the vascular wall, it is not clear whether or not circulating monocytes express the VLDL receptor. We investigated the expression of VLDL receptor mRNA in human peripheral blood monocytes and monocyte-derived macrophages by reverse transcriptase polymerase chain reaction (RT-PCR) and nucleotide sequencing after subcloning of PCR product. VLDL receptor mRNA was detected both in peripheral blood monocytes and monocyte-derived macrophages. Expression of VLDL receptor mRNA was upregulated by hypoxia in monocytes, whereas treatment with oxidized LDL, interleukin-1beta or monocyte chemoattractant protein-1 did not affect the levels of VLDL receptor mRNA in monocytes and macrophages. The present study shows a novel response of VLDL receptor mRNA to hypoxia, suggesting a role for VLDL receptor in the metabolism of lipoproteins in the vascular wall and the development of atherosclerosis.
Nakazato
K
K
First Department of Internal Medicine, Fukushima Medical University, 1 Hikarigaoaka, 960-1295, Fukushima, Japan.
Ishibashi
T
T
Nagata
K
K
Seino
Y
Y
Wada
Y
Y
Sakamoto
T
T
Matsuoka
R
R
Teramoto
T
T
Sekimata
M
M
Homma
Y
Y
Maruyama
Y
Y
D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology* / Q000378:metabolism; D015687:Cell Hypoxia / Q000235:genetics*; D002478:Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D018932:Chemokine CCL2 / Q000494:pharmacology; D005487:Foam Cells / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D007375:Interleukin-1 / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000494:pharmacology; D008264:Macrophages / Q000378:metabolism; D009000:Monocytes / Q000378:metabolism*; D020319:Oligodeoxyribonucleotides, Antisense / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000097:blood*; D011973:Receptors, LDL / Q000096:biosynthesis / Q000235:genetics*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology; D020133:Reverse Transcriptase Polymerase Chain Reaction
D018932:Chemokine CCL2; D007375:Interleukin-1; D008077:Lipoproteins, LDL; D020319:Oligodeoxyribonucleotides, Antisense; D012333:RNA, Messenger; D011973:Receptors, LDL; D011993:Recombinant Fusion Proteins; C036053:VLDL receptor; C099252:oxidized low density lipoprotein